Fort-Casamartina, E.; Pernas, S.; Otero, S.; Mate, P.; Gonzalo, N.; Narváez, S.; Rigo-Bonnin, R.; Padró-Miquel, A.; Teulé, À.; Garcia del Muro, X.;
et al. Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project). J. Clin. Med. 2025, 14, 145.
https://doi.org/10.3390/jcm14010145
AMA Style
Fort-Casamartina E, Pernas S, Otero S, Mate P, Gonzalo N, Narváez S, Rigo-Bonnin R, Padró-Miquel A, Teulé À, Garcia del Muro X,
et al. Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project). Journal of Clinical Medicine. 2025; 14(1):145.
https://doi.org/10.3390/jcm14010145
Chicago/Turabian Style
Fort-Casamartina, Eduard, Sonia Pernas, Sara Otero, Paula Mate, Núria Gonzalo, Sonia Narváez, Raúl Rigo-Bonnin, Ariadna Padró-Miquel, Àlex Teulé, Xavier Garcia del Muro,
and et al. 2025. "Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project)" Journal of Clinical Medicine 14, no. 1: 145.
https://doi.org/10.3390/jcm14010145
APA Style
Fort-Casamartina, E., Pernas, S., Otero, S., Mate, P., Gonzalo, N., Narváez, S., Rigo-Bonnin, R., Padró-Miquel, A., Teulé, À., Garcia del Muro, X., Peiró, I., Arribas, L., Esteve, A., Gonzalez, A., Rey, M., Clopés, A., Fontanals, S., & Muñoz, C.
(2025). Everolimus Through Plasmatic Concentrations in Cancer Patients: Prospective Longitudinal Observational Multicentric Study (DIANA-1 Project). Journal of Clinical Medicine, 14(1), 145.
https://doi.org/10.3390/jcm14010145
